Antimicrobial Resistance (AMR) –– A Threat Continues Emerging in Covid 19 Pandemic & Role of Antimicrobial Stewardship Programmes (ASPs)

Abstract

A Novel coronavirus (CoV) named ‘2019-nCoV’ or ‘COVID 19 by the World Health Organisation (WHO) could be a disease of respiratory and gastrointestinal tracts infections that's extremely transmissible and dangerous. Covid19 has reached to a hundred and fifty nations, together with China the place wherever eruption of respiratory disorder started at the beginning of Dec 2019 pass on metropolis town, Hubei Territory, China, and that has swayed  WHO to decide the disease around the world a pandemic.¹ Currently it is reported to have caused around 199M infections and 4.24 million deaths on a worldwide scale within the Year of 2019 and 2020. Prompt Detection and Treatment of Covid-19 is crucial to intercept the proliferation and transmission of the disease. Within the case of Antimicrobial resistance (AMR) a rampant use of broad spectrum antibiotics (BSA) in treatment of COVID19, a microorganism infection: associate degree calculable 75% of COVID19 patients got antibiotics (ABX) against co-infections and secondary infections².